DE1670069A1 - Process for the preparation of pyrimidines substituted in the 5-position by halogen - Google Patents
Process for the preparation of pyrimidines substituted in the 5-position by halogenInfo
- Publication number
- DE1670069A1 DE1670069A1 DE19661670069 DE1670069A DE1670069A1 DE 1670069 A1 DE1670069 A1 DE 1670069A1 DE 19661670069 DE19661670069 DE 19661670069 DE 1670069 A DE1670069 A DE 1670069A DE 1670069 A1 DE1670069 A1 DE 1670069A1
- Authority
- DE
- Germany
- Prior art keywords
- radical
- phenyl
- parts
- alkyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 11
- 238000002360 preparation method Methods 0.000 title claims description 5
- 229910052736 halogen Inorganic materials 0.000 title claims description 4
- 150000002367 halogens Chemical class 0.000 title claims description 3
- 150000003230 pyrimidines Chemical group 0.000 title description 4
- -1 cycloalkyl radical Chemical class 0.000 claims description 27
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 150000003254 radicals Chemical class 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 150000002431 hydrogen Chemical class 0.000 claims description 6
- 150000005840 aryl radicals Chemical class 0.000 claims description 5
- 239000002585 base Substances 0.000 claims description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- UHIAFEYAASZXLP-UHFFFAOYSA-N 5-chloro-2-phenylpyrimidin-4-amine Chemical compound C1=C(Cl)C(N)=NC(C=2C=CC=CC=2)=N1 UHIAFEYAASZXLP-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- ABOGUIRTXHNENF-UHFFFAOYSA-N (5-bromo-2-phenylpyrimidin-4-yl)hydrazine Chemical compound C1(=CC=CC=C1)C1=NC=C(C(=N1)NN)Br ABOGUIRTXHNENF-UHFFFAOYSA-N 0.000 claims 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims 1
- ZLNPDTOTEVIMMY-UHFFFAOYSA-N 5-chloropyrimidine Chemical compound ClC1=CN=CN=C1 ZLNPDTOTEVIMMY-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- VASKWKROZNSZGG-UHFFFAOYSA-N 4,5-dichloro-2-phenylpyrimidine Chemical compound N1=C(Cl)C(Cl)=CN=C1C1=CC=CC=C1 VASKWKROZNSZGG-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- HCARWKTUTSXQGA-UHFFFAOYSA-N 5-chloro-4-methoxy-2-phenylpyrimidine Chemical compound C1=C(Cl)C(OC)=NC(C=2C=CC=CC=2)=N1 HCARWKTUTSXQGA-UHFFFAOYSA-N 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- BSWWXRFVMJHFBN-UHFFFAOYSA-N 2,4,6-tribromophenol Chemical compound OC1=C(Br)C=C(Br)C=C1Br BSWWXRFVMJHFBN-UHFFFAOYSA-N 0.000 description 2
- ZXTHWIZHGLNEPG-UHFFFAOYSA-N 2-phenyl-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=CC=CC=C1 ZXTHWIZHGLNEPG-UHFFFAOYSA-N 0.000 description 2
- MQWCXKGKQLNYQG-UHFFFAOYSA-N 4-methylcyclohexan-1-ol Chemical compound CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 description 2
- GYCPLYCTMDTEPU-UHFFFAOYSA-N 5-bromopyrimidine Chemical compound BrC1=CN=CN=C1 GYCPLYCTMDTEPU-UHFFFAOYSA-N 0.000 description 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 102100022404 E3 ubiquitin-protein ligase Midline-1 Human genes 0.000 description 2
- 101710102210 E3 ubiquitin-protein ligase Midline-1 Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 210000000548 hind-foot Anatomy 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 2
- 229960005222 phenazone Drugs 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- FBMMEHJLWTZKOR-SOFGYWHQSA-N (1e)-cycloocten-1-ol Chemical compound O\C1=C\CCCCCC1 FBMMEHJLWTZKOR-SOFGYWHQSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- HIZVCIIORGCREW-UHFFFAOYSA-N 1,4-dioxene Chemical compound C1COC=CO1 HIZVCIIORGCREW-UHFFFAOYSA-N 0.000 description 1
- NDOVLWQBFFJETK-UHFFFAOYSA-N 1,4-thiazinane 1,1-dioxide Chemical compound O=S1(=O)CCNCC1 NDOVLWQBFFJETK-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- HFZWRUODUSTPEG-UHFFFAOYSA-N 2,4-dichlorophenol Chemical compound OC1=CC=C(Cl)C=C1Cl HFZWRUODUSTPEG-UHFFFAOYSA-N 0.000 description 1
- HNVIQLPOGUDBSU-UHFFFAOYSA-N 2,6-dimethylmorpholine Chemical compound CC1CNCC(C)O1 HNVIQLPOGUDBSU-UHFFFAOYSA-N 0.000 description 1
- UCJMHYXRQZYNNL-UHFFFAOYSA-N 2-Ethyl-1-hexanethiol Chemical compound CCCCC(CC)CS UCJMHYXRQZYNNL-UHFFFAOYSA-N 0.000 description 1
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
- PQSBRHXGVPVYFJ-UHFFFAOYSA-N 4-(dimethylamino)benzenethiol Chemical compound CN(C)C1=CC=C(S)C=C1 PQSBRHXGVPVYFJ-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- DJXQYJXQDQXQTG-UHFFFAOYSA-N 4-hydroxythiomorpholine Chemical compound ON1CCSCC1 DJXQYJXQDQXQTG-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- DSJKDIQHKUBCBI-UHFFFAOYSA-N 6-amino-1,4-dimethylcyclohexa-2,4-dien-1-ol Chemical compound NC1C(C=CC(=C1)C)(C)O DSJKDIQHKUBCBI-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000724822 Teia Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 230000003501 anti-edematous effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940045984 antineoplastic methylhydrazine Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- SFVWPXMPRCIVOK-UHFFFAOYSA-N cyclododecanol Chemical compound OC1CCCCCCCCCCC1 SFVWPXMPRCIVOK-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 150000002258 gallium Chemical class 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052740 iodine Chemical group 0.000 description 1
- 239000011630 iodine Chemical group 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
Verfahren zur Herstellung von in 5-Stellung durch Halogen substituiertexi:'Pyrimidinen Es wurde gefunden, daß man in-5-Stellung durch Halogen aubstituierte Pyrimidine der Formel worin Ri Wasserstoff, einen Alkyl-e Cyeloalkyl-, Aralkyl- oder einen gegebenenfalls durch unter den Reaktionabedingunggn sich inert verhaltende Substituenten substituierten Arylreat, X, ein Halogenatom und Y für den Rest -Z-R2t worin Z ein $äuerstoff-oder Schwefelatom und R Wasserstoff oder einen gegebenenfalls 2 durch Halogen, Nitro-, Alkoxy- oder sekundäre 4minogruppen aubetituierten Alkyl-, Aralkyl-" Aryl- oder Cycloalkylrest bedeuten, für den Rest worin R 3 und R 4 Wasserstoff, Alkyl-, Cycloalkyl-, Aralkyl- oder-Ärylreste bedeuten und R und-R auch gemeinsam einen Alkylenrest 3 4 mit 2 bis 6 Kohlenstoffatomen bilden können, in dem eine Methylengi#uppe durch ein Sauerstoff- oder Schwefelatom, durch eine der Gruppen sog so 2 9der.##N-H 59 worin R5 einen Alkyl-, Cycloalkyl-oder den Phenylrest bedeutet, ersetzt seiri kann, für den Rest worin R 29 R3 und R 4 die zuvorgenannte Bedeutung haben, oder für den Rest -N stehte in guten Ausbeuten und auf einfache Weise er-3.Process for the preparation of halogen-substituted in the 5-position: pyrimidines It has been found that halogen-substituted pyrimidines of the formula in which Ri is hydrogen, an alkyl-e cyeloalkyl-, aralkyl- or an arylrean which is optionally substituted by substituents which are inert under the reaction conditions, X is a halogen atom and Y is the radical -Z-R2t in which Z is an oxygen or sulfur atom and R Denotes hydrogen or an alkyl, aralkyl, aryl or cycloalkyl radical which is optionally 2 substituted by halogen, nitro, alkoxy or secondary 4mino groups, for the radical wherein R 3 and R 4 are hydrogen, alkyl, cycloalkyl, aralkyl or aryl radicals and R and -R can also together form an alkylene radical 3 4 with 2 to 6 carbon atoms in which a methylene group is replaced by an oxygen or sulfur atom, by one of the groups known as 2 9The. ## NH 59 wherein R 5 is an alkyl, cycloalkyl or represents the phenyl radical may sem replaced, for the rest wherein R 29, R3 and R 4 have the abovementioned meaning, or the radical -N stands in good yields and in a simple manner as er-3.
hält, wenn man 4,5-Dihalogen-pyrimidine der Formel
worin R 1 und X die zuvorgenannte Bedeutung haben, mit einer-Verbindung,
die die allgemeine Formel H y Iii besitzt, worin Y die zuvorgenannte Bedeutung
hat, gegebenenfalls .in Gegenwart einer Base, oder mit einem Alkalt- oder Erdelkaliaalz
der Verbindung HY bei Temperaturen zwischen 30 und 200 0 C,
gegebenenfalls
in Gegenwart eines lösungsmittels und gegebenen-,falle bei erhöhtem Druck" umsetzt.
Bevorzugt führt man das Verfahren bei Temperaturen zwischen 50 und
150 OC durch.
Das Verfahren läßt sich für die Herstellung
von 2-Phenyl-4-Methoxy. 5-ohlorpyrimidin durch Umsetzung von 2-Phenyl-4,5-dichlorpyrimidin
mit Natriummethylet durch folgende Reaktionagleichung wiedergeben:
Die als Ausgangestoffe verwendeten 4,5-Dihalogenpyrimidine der Formel II sind neue
Stoffe. Sie lassen sich durch Umsetzung von z.B. 4-Hydroxy-5-halogenpyrimidinen,
d.ie ihrerseits durch Umsetzung von z.B. 2,3-Dihalogenacrylsäureäthylester mit Amidinen
erhalten werden könneng mit z.B. Phosphoroxyhalogeniden in Gegenwart eines tertiären
Amine einfach herstellen. Bevorzugte Ausgangepyrimidine sind solche, in denen in
der Formel II X für Chlor, Brom oder Jod und R 1 für Wasserstoff, einen Alkylrest
mit 1 bis 6
Kohlenstoffetomen, einen Cycloalkylrest mit 5 bis
12 Kohlenstoffstomen, einen Aralkylrest mit 7 bis 9 Kohlenstoffetomen
oder einen Arylrest mit 6 bis 12 Kohlenstoffatomen steht.. Ferner kann der
Arylrest in den bevorzugten Ausgen gspyrimidinen noch durch 1 bis
3
uritee den Reaktionabedingungen sich inert verhaltende Substituenten, wie
Chlor, Brom, Jod, Nitrogruppen, Alkyl-, Alkoxy- oder Alkylmerka,ptoreste mit vorzugsweise
jeweils 1 bis-4 Kohlenstoffatomen, substituiert:-sein.
Andere geeignete Ausgangestoffä, die unter die allgemeine Formel III
falleng sind Ammoniak, primäre und s-ekundäre Amine. In diesem Fall bedeutet der
Rest Y die Gruppe
Weiterhin lassen sich auch Hydrazin sowie aubstituierte Hydrazine umsetzen. Sie lassen sich durch die allgemeine Formel III wiedergeben, wobei Y für den Rest steht. In der Formel bedeuten die Reste. R29 R 3 und R 4 Vorzugsweise Waaaerstoffi einen Alkylrest mit 1 bis 4 Kohlenstoffstomen und sofern R2 und R 3 Wasserstoff bedeuten, steht R 4 für eine Phenylrest. Einzelne Vertreter der bevorzugt verwendeten Hydrezine sind z.B. Hydrazin, Methylhydrezin, symmetrisch oder eseymmetriech aubstituierte Methylhydrazine - sie werden zweckmäßigerweise in Form ihrer Hydrate oder als wäserige Lösungen-angewandt sowie Phenylhydrasin. Schließlich kann man für die Umeetzung auch StiokatQ£fwasseratoffeäureg vorzugsweise in Form eines Alkälisalzen, verwenden.Furthermore, hydrazine and substituted hydrazines can also be converted. They can be represented by the general formula III, where Y is the remainder stands. In the formula, the radicals mean. R29, R 3 and R 4 are preferably an alkyl radical having 1 to 4 carbon atoms and if R2 and R 3 are hydrogen, R 4 is a phenyl radical. Individual representatives of the hydrezines used with preference are, for example, hydrazine, methylhydrazine, symmetrically or eseymmetrically substituted methylhydrazines - they are expediently used in the form of their hydrates or as aqueous solutions, and also phenylhydrazine. Finally, StiokatQ £ fwasseratoffeäureg, preferably in the form of an alkali salt, can also be used for the conversion.
Als Basen kann man im Rahmen dieser Erfindung die Alkoholatep die Yhenolatep die Oxydee Hydroxyde und Carbonate der Alkeli- ünd Brdalkellmetalleg insbesondere des Natriumag Kaliume, Caleiums und Bariums verwenden, Weitere geeignete Basen sind tertiäre Aminel, wie Dimethylaniling Diäthylanilin, Tributylamin und Pyridin. In der Regel verwendet man soviel an Basel daß der bei-'#-der Umsetzung sich bildende Halogenwasserstoff neutralisiert wird. Man kann jedoch auch einen Überschuß an Base verwenden.As bases, in the context of this invention, the alcoholate can be used Yhenolatep the oxydes, hydroxides and carbonates of the Alkeli- and Brdalkellmetalleg Use especially of the sodium ag, potassium, calium and barium, other suitable ones Bases are tertiary amines, such as dimethylaniling, diethylaniline, tributylamine and Pyridine. As a rule, so much is used in Basel that the two - '# - the implementation hydrogen halide which forms is neutralized. However, you can also do one Use excess base.
Das Verfahren kann in Gegenwart oder Abwesenheit eines Lösungemittels durchgeführt werden. Als Lösungsmittel kann man Alkanole, vorzugsweise mit 1 bis 6 Kohlenstoffatomen, wie Methanol, Äthanolg Propanol oder iso-Butanol, Äther, wie Dibutyläther, Dioxen oder Tetrahydrofuran, N,N-diaubstituierte Carbonsäureamide, wie Dimethylformamid, Diäthylformamid, Dimethylacetamid, N-Methylpyrrolidon oder Tetramethylhernstoff, oder Sulfolan verwenden.The process can be carried out in the presence or absence of a solvent. The solvent can be alkanols, preferably with 1 to 6 carbon atoms, such as methanol, ethanol, propanol or isobutanol, ethers such as dibutyl ether, dioxene or tetrahydrofuran, N, N-diaubstituted carboxamides, such as dimethylformamide, diethylformamide, dimethylacetamide, or N-methylpyrrolidone Use tetramethyl ether or sulfolane.
Bei der Durchführung des Verfahrens werden die Ausgangestoffe möglichst im'Molverhältnie 1 : 1 angewandt. Es'kann aber auch ein Überschuß an der Verbindung der Formel III verwendet werden. Setzt man einen leicht flüchtigen Reaktioneteilnehmer um, so ist es zweckmäßig, das Verfahren unter erhöhtem Druck durchzuführen. Dabei kann der Druck innerhalb weiter Grenzen schwanken. Der anzuwendende Druck ist von der Reaktionstemperatur abhängig, bei der gearbeitet werden-soll. In der Regel reicht die Anwendung eines Pruckee von bis zu etwa 100 et aus.When carrying out the process, the starting materials are used in a molar ratio of 1: 1, if possible. However, an excess of the compound of the formula III can also be used. If a volatile reaction participant is reacted, it is advisable to carry out the process under increased pressure. The pressure can fluctuate within wide limits. The pressure to be used depends on the reaction temperature at which the work is to be carried out. As a rule, the use of a Pruckee of up to about 100 et is sufficient.
Die nach dem Verfahren herstellbaren neuen Verbindungen sind wertvolle Zwischenprodukte fUr die Herstellung von Pharmazeutikaj einige von ihnen haben antiphlogistische Eigenschaften.The new compounds which can be prepared by the process are valuable intermediates for the preparation of pharmaceuticals some of them have anti-inflammatory properties.
Die entzUndungshemmende Wirkung wird bei der FrÜfung (s. Tabelle) nach der Methode von C.A. Winter, E.A. Risley und G.W. Nuss, Prob. See. exp. Biol. Med. 111 (1962) "Carrageenin Induced Edema in Hind Paw of the Rat ae an Assay for Antiinflammatory Drugell, S-. 544, an dem durch Carrageenin erzeugten Oedem an der Hinterpfote von Ratten bestimmt.The anti-inflammatory effect is determined when testing (see table) using the method of CA Winter, EA Risley and GW Nuss, Prob. Lake. exp. Biol. Med. 111 (1962) "Carrageenin Induced Edema in Hind Paw of the Rat ae an Assay for Antiinflammatory Drugell, S-. 544, determined on the edema produced by carrageenin on the hind paw of rats.
Bei dieser Methode wird durch Injektion von Garrageenin in die Hinterpfote
der Ratte eine entzündliche Schwellung erzeugt. Die Schwellung kann in ihrem Ausmase
durch antiphlogistisch wirkende Substanzen verhindert bzw. abgeschwächt werden.
Diese Abschwächung wird als % Hemmung des ohne Vorbehandlung entstehenden
Oedeme aüsgedrückt. Die Grösse der entzündlichen Schwellung wird nach
Ab-
schneiden der Ratenpfoten durch Wiegen bestimmt.
bie in den Beispielen angeführten Teile bedeuten Gewichteteile. Beispiel 1 Zu einer Lösung von 5,4 Teilen Natrilimmethylat in 150 Teilen Methanol gibt man 22,5 Teile 2-Pheny1r495-dichlorpyrimidin und erhitzt 2 Stuhden unter' Rückfluß.Danach gießt man das Reaktionagemisch in 500 Teile Wasser und filtriert die ausgeschiedenen Kristalle ab. Nach Umkristallisieren aus Äthanol erhält man 18 Teile 2-Phenyl-4-methoxy-5-ohlorpyrimidin vom Ppe 77 00. Beispiel 2 Zu einer Lösung von 4 Teilen Natriumhydroxyd-in 150 Teilen Methenol gibt man 22,5 Teile 2-Phenyl-4,5-dichlorpyrimidin und erhitzt 2 Stunden unter Rückfluß.-Danach wird.wie in Beispiel 1 beschriebengaufgearbeitet. Man erhält 15 Teile 2-Phenyl-4-methoxy-5-ohlorpyrimidin vom FP- 77 0 0. The parts given in the examples are parts by weight. EXAMPLE 1 22.5 parts of 2-phenylr495-dichloropyrimidine are added to a solution of 5.4 parts of sodium dimethylate in 150 parts of methanol and the mixture is heated under reflux for 2 hours. The reaction mixture is then poured into 500 parts of water and the crystals which have separated out are filtered off. After recrystallization from ethanol, 18 parts of 2-phenyl-4-methoxy-5-chloropyrimidine from Ppe 77 00 are obtained. Example 2 22.5 parts of 2-phenyl-4 are added to a solution of 4 parts of sodium hydroxide in 150 parts of methenol. 5-dichloropyrimidine and refluxed for 2 hours.-Then, as described in Example 1 , work-up. 15 parts of 2-phenyl-4-methoxy-5-chloropyrimidine from FP- 77 0 0 are obtained.
BeiaRiel 3
Zu einer Lösung von 12,8 Teilen p-Ohlorphenol
in 200 Teilen absolutem DioxUn gibt man 2,3 Teile Natrium. Nach Lösung denselben
worden 245 Teile 2-PhenY1-495-dichlorpyrizidin zugegeben.und 6
Stunden unter
Rückfluß erhitzt. Danach wird, wie in Beispiel 1 be' schriebeng aufgearbeitet.
Man erhält 18 Teile 2-Phenyl-4-p-ohlorphonoxy-5-chlorpyrimidin vom Fp.
138 0 C. j
Auf analoge Weise erhält man
Beispiel 8 Eine Mischung von 10 Teilen 2-Phenyl-4,5-dichlorpyrimidin und 50 Teilen Iaobutylamin wird 4 Stunden unter Rückfluß erhitzt. Denn wird das überschüssige Iaobutylamin im Wasserstrahlvakuum abdestilliert und der Rückstand fraktioniert. Man erhält 10 Teile 2-Phenyl-4-isobutylamino-5-chlorpyrimidin vom Kp..,2 140 0 C und Pp. 44 0 C. Example 8 A mixture of 10 parts of 2-phenyl-4,5-dichloropyrimidine and 50 parts of iaobutylamine is refluxed for 4 hours. Because the excess iaobutylamine is distilled off in a water jet vacuum and the residue is fractionated. This gives 10 parts of 2-phenyl-4-isobutylamino-5-chloropyrimidine, bp .., 2 140 0 C and Pp. 44 0 C.
Auf analoge Weise erhält man
Beispiel 14 22,5 Teile 2-Phenyl-4,5-dichlorpyrimidin und 6,5 Teile Natriumazid werden in 300 Teilen 80-%igem wäserigem Äthanol 1 Stunde unter Rückfluß erhitzt. Danach wird mit Wasser verdünnt und das Umsetzungegemisch von den ausgeschiedenen Kristallen abgesaugt. Nach Umkristallisieren aus Ligroin erhält man 20 Teile 2-Phenyl-4-azido-5-chlorpyrimidin vom Fp. 112 0 C. Example 14 22.5 parts of 2-phenyl-4,5-dichloropyrimidine and 6.5 parts of sodium azide are refluxed in 300 parts of 80% strength aqueous ethanol for 1 hour. It is then diluted with water and the reaction mixture is filtered off with suction from the precipitated crystals. After recrystallization from 20 parts of ligroin gives 2-phenyl-4-azido-5-chloropyrimidine, mp. 112 0 C.
Beispiel 15 23,1 Teile 2-Cyclohexyl-4,5-dichlorpyrimiding 150 Teile Äthanol und 30 Teile konzentrierter Ammoniak werden 6 Stunden im Autoklaven auf 120 00 erhitzt. Anschließend wird in Wasser gegossen, abfiltriert und aus Benzol umkristallisiert. Man erhält 16 Teile 2-Cyclohexyl-4-amino-5-chlorpyrimidin vom Fp. 124 0 0. Example 15 23.1 parts of 2-cyclohexyl-4,5-dichlorpyrimiding 150 parts of ethanol and 30 parts of concentrated ammonia are heated at 120 00 6 hours in an autoclave. It is then poured into water, filtered off and recrystallized from benzene. 16 parts of 2-cyclohexyl-4-amino-5-chloropyrimidine with a melting point of 124,000 are obtained .
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US630829A US3503976A (en) | 1966-04-20 | 1967-04-14 | Production of pyrimidines bearing halogen as substituent in the 5-position |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB0086748 | 1966-04-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1670069A1 true DE1670069A1 (en) | 1970-01-02 |
Family
ID=6983501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19661670069 Pending DE1670069A1 (en) | 1966-04-20 | 1966-04-20 | Process for the preparation of pyrimidines substituted in the 5-position by halogen |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE1670069A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0055693A1 (en) * | 1980-12-23 | 1982-07-07 | Ciba-Geigy Ag | Use of phenyl pyrimidines as protecting agents for culture plants against phytotoxic damage caused by herbicides |
-
1966
- 1966-04-20 DE DE19661670069 patent/DE1670069A1/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0055693A1 (en) * | 1980-12-23 | 1982-07-07 | Ciba-Geigy Ag | Use of phenyl pyrimidines as protecting agents for culture plants against phytotoxic damage caused by herbicides |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1695940A1 (en) | Process for the preparation of 1,2-dihydro-1-hydroxypyrimidines | |
| DE69605746T2 (en) | NAPHTHOL DERIVATIVES AND A METHOD FOR THEIR PRODUCTION | |
| DE2119730C3 (en) | ||
| DE1900125A1 (en) | New heterocyclic compounds and processes for their preparation | |
| DE1809386A1 (en) | Process for the preparation of 1,5-disubstituted 4-cyanopyrazoles | |
| DE1595920A1 (en) | 4- (omega-piperazinoalkyl) pyrazoles, their salts and processes for their preparation | |
| DE2119730B2 (en) | PROCESS FOR THE PREPARATION OF 1,2-BENZISOTHIAZOLIN-3-ONE | |
| DE2141616B2 (en) | Oxazolo- and Oxazine square bracket on 3.2-c square bracket for quinazolinone, process for their preparation and medicinal products containing these compounds | |
| DE1237580B (en) | Process for the preparation of 3-phenylamino-2-pyrazolin-5-ones substituted in the 1-position | |
| DE1670069A1 (en) | Process for the preparation of pyrimidines substituted in the 5-position by halogen | |
| DE2537379A1 (en) | SUBSTITUTED 2-PHENYLIMINO-1,3-DITHIOLANES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS EECTOPARASITICIDALS | |
| DE1935404B2 (en) | Process for the manufacture of quinazolinones | |
| DE2406972C3 (en) | Process for the preparation of 5-sulfamoylanthranilic acids | |
| DE1593871A1 (en) | Process for the preparation of nitroaminodiarylaethers | |
| DE1129947B (en) | Process for the preparation of 1,4-bis (p-carboxystyryl) -benzenes | |
| DE1812231B2 (en) | PROCESS FOR THE PREPARATION OF 3ALKYL-5-PHENYL-1,3-DIHYDRO-2H-1,4BENZODIAZEPIN-2-ONE DERIVATIVES | |
| DE2632656A1 (en) | PROCESS FOR THE PRODUCTION OF PHTHALAZINONE AND ITS DERIVATIVES | |
| DE1543612A1 (en) | Process for the preparation of alkyl mercaptoanilides | |
| DE1933525A1 (en) | Process for the preparation of chlorine- and / or cyano-substituted hydroxybenzonitriles or their alkali or alkaline earth metal salts | |
| EP0320750B1 (en) | Process for the preparation of 4-substituted-3-methyl-1-aryl-5-amino-pyrazoles | |
| DE3516631A1 (en) | Process for the preparation of 3-methyl-1,3,5-triazinetriones | |
| DE1234223B (en) | Process for the preparation of pyrazole derivatives | |
| DE1200313B (en) | Process for the preparation of 3, 5-dioxo-1, 2, 4-triazolidines | |
| EP0129170B1 (en) | Triazolyl ketoximes and dioximes, process for their preparation and their use as plant-growth regulators | |
| DE1545831A1 (en) | Process for the preparation of derivatives of 3-phenylpyrrole |